6550--DNA Extraction Reagents Minneapolis VA Health Care System

SOL #: 36C26326R0054_0002Special Notice

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NETWORK CONTRACT OFFICE 23 (36C263)
Saint Paul, MN, 55101, United States

Place of Performance

Minneapolis, MN

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
May 8, 2026
2
Action Date
May 15, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the NETWORK CONTRACT OFFICE 23 (36C263), has issued Amendment 2 to the Request for Quote (RFQ) for DNA Extraction Reagents for the Minneapolis VA Health Care System. This amendment extends the deadline for quote submissions and adds specific clauses and provisions. Quotes are now due by May 15, 2026, at 4:00 PM Central Time.

Scope of Change

  • The due date for receipt of quotes has been extended to May 15, 2026, at 4:00 PM Central Time.
  • Provision 52.219-1 (SMALL BUSINESS PROGRAM REPRESENTATIONS (NOV 2025) (DEVIATION)) has been added.
  • Clause 52.225-3 (BUY AMERICAN-FREE TRADE AGREEMENTS-ISRAELI TRADE ACT (DEVIATION)) has been added.

Contract & Timeline

  • Contract Opportunity Type: Special Notice (Amendment to RFQ)
  • Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
  • Place of Performance: Minneapolis, MN
  • Set-Aside: None specified
  • Response Due: May 15, 2026, 4:00 PM CT
  • Published Date: May 8, 2026

Additional Notes

Offerors must review and acknowledge the newly added provision and clause. To remain eligible for consideration, offerors are instructed to sign and return this amendment immediately to the Contract Specialist, Robert Bennett, at robert.bennett8@va.gov.

People

Points of Contact

Robert BennettContract SpecialistPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: May 8, 2026
6550--DNA Extraction Reagents Minneapolis VA Health Care System | GovScope